AWH News and Press, Aspira Women's Health Inc. From 02/04/21

AUSTIN, Texas, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH) (“Aspira”), a bio-analytical based women’s health company focused on gynecologic disease, today announced the pricing of the previously announced underwritten public offerin...

AUSTIN, Texas, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH) (“Aspira”), a bio-analytical based women’s health company focused on gynecologic disease, today announced it has commenced an underwritten public offering of shares of its c...

AUSTIN, Texas, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that it expanded access and has become a participating laboratory network provider, for all Pennsylvania and West Virginia c...

Aspira Women's Health Inc. (AWH) has filed for a $100 million mixed shelf offering.As of Jan. 20, 2021, the company had 104,622,376 shares of outstanding stock, and 7,931,239 shares were subject to outstanding options.In September 2020, Aspira filed to sell 3.15 million shares of common stock...

It's hard to think of an industry that was more impacted by the 2020 COVID pandemic than diagnostics. The often-overlooked part of the healthcare system sprang into action, testing more than 250 million people last year in the U.S. alone. And interestingly, some testing companies performed ...

Aspira to participate in the 10 th Annual LifeSci Advisors Corporate Access Event and Biotech Showcase™ from January 6 – 15 th , 2021 AUSTIN, Texas, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioa...

Aspria has rallied more than 1,200% from the bottom earlier this year. However, it looks to me like this is nothing more than hopes and dreams. With massive, sustained dilution and a tenuous path to revenue growth, I'm extremely bearish on Aspira. For further details see: ...

The oncology market covers every area of cancer care, from diagnosis to treatment, and is one of the biggest sectors in the life science space. Cancer is the second leading cause of death worldwide, after cardiovascular diseases. Biotechnology and pharmaceutical companie...

AUSTIN, Texas, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced it has entered into a collaborative research agreement with Baylor Genetics (Houston, TX) to co-develop a novel Ovarian Can...

Aspira Women's Health Inc. (AWH) Q3 2020 Earnings Conference Call November 12, 2020, 04:30 PM ET Company Participants Valerie Palmieri - CEO, President & Director Robert Beechey - CFO Conference Call Participants Presentation Operator Hello ladies and gentlemen. Good afternoon, and welcom...